Thissiteisoptimized with the Yoast SEO plugin v22.3 - https://yoast.com/wordpress/plugins/seo/ 

 / Yoast SEO plugin. 

 HFCM by 99 Robots - Snippet # 3: Google Analytics 

 /end HFCM by 99 Robots 
 HFCM by 99 Robots - Snippet # 2: GDPR 

 /end HFCM by 99 Robots 

Core Values
Investors, Grants & Awards

Core Values
Investors, Grants & Awards

Read our latest news and get updated information about MedTrace Pharma 

 Gridbuilder ᵂᴾ Plugin (https://wpgridbuilder.com) 

News
First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace 

First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace CEO Ann Kristin Led and CTO Lars Trolle in front of MedTrace’s automated...News
Shrinking the Manufacturing Footprint with PET Point-of-Care

Shrinking the Manufacturing Footprint with PET Point-of-Care Jared Driskill, Sr. Medical Advisor at MedTrace “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed....News
The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published

The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published MedTrace is proud to see the methodology paper “Rationale and design of the...News
MedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial

MedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial Installation of MedTrace’s point-of-care manufacturing system, P3 MT-100....News
MedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace

MedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace Ann Kristin Led Pharmaceutical and medical device company...News
New Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle​

New Research Concludes That 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle At MedTrace we keep a close eye on...News
MedTrace Is Proud to Sponsor the Women in Nuclear Cardiology Event at ASNC2023

MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023,...News
MedTrace Receives an 18 Million Euro Investment for Completion of Its Phase 3 Trial

MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed...News
15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System

15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System 15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and...ClinicalNews
MedTrace Hosts 15O-Water Symposium for Nuclear Medicine Professionals

MedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September...News
MedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology

MedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology The new patent protects how the company’s automated manufacturing system, P3 MT-100, produces and doses the...News
MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting

MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the...ClinicalNews
MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices

MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical...ClinicalNews
First U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 Trial

First U.S. Patient Scanned in MedTrace’s 15O-Water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned...ClinicalNews
New Findings from Aarhus University Hospital Shed Light on How 15O-Water PET MPI May Benefit Patients with Bypass Surgery

New findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a...ClinicalNews
Aarhus University Hospital Documents Frequent Extracardiac Findings on 15O-Water PET Myocardial Perfusion Imaging

Aarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers...ClinicalNews
First Oncology Patient Scanned with 15O-Water on MedTrace Equipment

First Oncology Patient Scanned with 15O-Water on MedTrace Equipment MedTrace’s automated manufacturing system at the installation at The Department of Nuclear Medicine and Tracer Kinetics...ClinicalNews
MedTrace Receives U.S. Patent for Diagnosing the Human Heart

MedTrace Receives U.S. Patent for Diagnosing the Human Heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the...News
CEO Stepping Down; MedTrace Will Intensify Its Efforts to Complete the Phase 3 Clinical Trial

CEO stepping down MedTrace will intensify its efforts to complete the phase 3 clinical trial MedTrace will intensify efforts to complete its phase 3 clinical...ClinicalNews
15O-Water Myocardial Perfusion Imaging: A Practical Approach to Simplifying the Gold Standard for Approved Clinical Use

15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans”... 

Meet our team and learn about our backgrounds. 

Investors, Grants & Awards 

Read about our investors, grants and awards we have received.